Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

1.

Adjuvant chemotherapy with an oral fluoropyrimidine, S-1, following reduced RADPLAT in advanced laryngeal cancer.

Wakisaka N, Kondo S, Endo K, Murono S, Yoshizaki T.

Ann Otol Rhinol Laryngol. 2012 Aug;121(8):555-62.

PMID:
22953663
[PubMed - indexed for MEDLINE]
2.

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine.

Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, Furukawa H, Nakajima T, Ohashi Y, Imamura H, Higashino M, Yamamura Y, Kurita A, Arai K; ACTS-GC Group.

N Engl J Med. 2007 Nov 1;357(18):1810-20. Erratum in: N Engl J Med. 2008 May 1;358(18):1977.

PMID:
17978289
[PubMed - indexed for MEDLINE]
Free Article
3.

Concurrent intra-arterial chemotherapy and radiotherapy for advanced laryngeal cancer.

Yoshizaki T, Kondo S, Wakisaka N, Murono S, Kitagawa N, Tsuji A, Nakashima M, Sanada J, Matsui O.

Ann Otol Rhinol Laryngol. 2009 Mar;118(3):172-8.

PMID:
19374147
[PubMed - indexed for MEDLINE]
4.

A phase II study of oral S-1 with concurrent radiotherapy followed by chemotherapy with S-1 alone for locally advanced pancreatic cancer.

Shinchi H, Maemura K, Mataki Y, Kurahara H, Sakoda M, Ueno S, Hiraki Y, Nakajo M, Natsugoe S, Takao S.

J Hepatobiliary Pancreat Sci. 2012 Mar;19(2):152-8. doi: 10.1007/s00534-011-0400-y.

PMID:
21647560
[PubMed - indexed for MEDLINE]
5.

Phase II study of preoperative concurrent chemoradiation therapy with S-1 in patients with T4 oral squamous cell carcinoma.

Nomura T, Murakami R, Toya R, Teshima K, Nakahara A, Hirai T, Hiraki A, Nakayama H, Yoshitake Y, Ota K, Obayashi T, Yamashita Y, Oya N, Shinohara M.

Int J Radiat Oncol Biol Phys. 2010 Apr;76(5):1347-52. doi: 10.1016/j.ijrobp.2009.03.055. Epub 2009 Jul 21.

PMID:
19628343
[PubMed - indexed for MEDLINE]
6.

Concurrent chemoradiotherapy with S-1 and cisplatin in advanced esophageal cancer.

Cho SH, Shim HJ, Lee SR, Ahn JS, Yang DH, Kim YK, Nam TK, Lee JJ, Kim HJ, Chung IJ.

Dis Esophagus. 2008;21(8):697-703. doi: 10.1111/j.1442-2050.2008.00837.x. Epub 2008 Jun 2.

PMID:
18522639
[PubMed - indexed for MEDLINE]
7.

A multicenter phase II study of adjuvant chemotherapy with oral fluoropyrimidine S-1 for non-small-cell lung cancer: high completion and survival rates.

Tsuchiya T, Nagayasu T, Yamasaki N, Matsumoto K, Miyazaki T, Tagawa T, Nakamura A, Minami H, Taniguchi H, Akamine S, Hisano H, Taniguchi Y.

Clin Lung Cancer. 2012 Nov;13(6):464-9. doi: 10.1016/j.cllc.2012.01.005. Epub 2012 Mar 14.

PMID:
22424872
[PubMed - indexed for MEDLINE]
8.
9.

Randomized scheduling feasibility study of S-1 for adjuvant chemotherapy in advanced head and neck cancer.

Tsukuda M, Kida A, Fujii M, Kono N, Yoshihara T, Hasegawa Y, Sugita M; Chemotherapy Study Group of Head and Neck Cancer.

Br J Cancer. 2005 Oct 17;93(8):884-9.

PMID:
16189518
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

[The feasibility of oral fluoropyrimidines as adjuvant chemotherapy after resection and local coagulation therapy of colorectal liver metastases].

Narita T, Seshimo A, Itabashi M, Aratake K, Ogawa S, Hirosawa T, Hashimoto T, Amano K, Kameoka S.

Gan To Kagaku Ryoho. 2011 Nov;38(11):1821-4. Japanese.

PMID:
22083190
[PubMed - indexed for MEDLINE]
11.

Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer.

Lee SJ, Cho SH, Yoon JY, Hwang JE, Bae WK, Shim HJ, Chung IJ.

Cancer Chemother Pharmacol. 2009 Dec;65(1):159-66. doi: 10.1007/s00280-009-1019-4. Epub 2009 May 29.

PMID:
19479256
[PubMed - indexed for MEDLINE]
12.

Intra-arterial chemotherapy less intensive than RADPLAT with concurrent radiotherapy for resectable advanced head and neck squamous cell carcinoma: a prospective study.

Yoshizaki T, Wakisaka N, Murono S, Kondo S, Shimizu Y, Takanaka T, Sanada J, Terayama N, Matsui O, Furukawa M.

Ann Otol Rhinol Laryngol. 2007 Oct;116(10):754-61.

PMID:
17987781
[PubMed - indexed for MEDLINE]
13.

[Long-term results of S-1 administration as adjuvant chemotherapy for advanced head and neck cancer].

Tsukuda M, Kida A, Fujii M, Kono N, Yoshihara T, Hasegawa Y, Sugita M.

Gan To Kagaku Ryoho. 2007 Aug;34(8):1215-25. Japanese.

PMID:
17687202
[PubMed - indexed for MEDLINE]
14.

Disease control, survival, and functional outcome after multimodal treatment for advanced-stage tongue base cancer.

Malone JP, Stephens JA, Grecula JC, Rhoades CA, Ghaheri BA, Schuller DE.

Head Neck. 2004 Jul;26(7):561-72.

PMID:
15229898
[PubMed - indexed for MEDLINE]
15.

High response rates in patients with pancreatic cancer using the novel oral fluoropyrimidine S-1.

Hayashi K, Imaizumi T, Uchida K, Kuramochi H, Takasaki K.

Oncol Rep. 2002 Nov-Dec;9(6):1355-61.

PMID:
12375048
[PubMed - indexed for MEDLINE]
16.

S-1 monotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck after progression on platinum-based chemotherapy.

Yokota T, Onozawa Y, Boku N, Hamauchi S, Tsushima T, Taniguchi H, Todaka A, Machida N, Yamazaki K, Fukutomi A, Yasui H.

Jpn J Clin Oncol. 2011 Dec;41(12):1351-7. doi: 10.1093/jjco/hyr147. Epub 2011 Oct 5.

PMID:
21980053
[PubMed - indexed for MEDLINE]
Free Article
17.

Radiotherapy combined with transcatheter arterial infusion of cisplatin versus oral fluoropyrimidine anticancer agent for locally advanced carcinoma of the uterine cervix: a prospective follow-up study.

Nagai N, Oshita T, Murakami J, Shigemasa K, Hirokawa Y, Ohama K.

Oncol Rep. 2001 Jan-Feb;8(1):119-25.

PMID:
11115582
[PubMed - indexed for MEDLINE]
18.

Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: results of Eastern Cooperative Oncology Group Study E2399.

Cmelak AJ, Li S, Goldwasser MA, Murphy B, Cannon M, Pinto H, Rosenthal DI, Gillison M, Forastiere AA.

J Clin Oncol. 2007 Sep 1;25(25):3971-7.

PMID:
17761982
[PubMed - indexed for MEDLINE]
Free Article
19.

A phase 2 trial of surgery with perioperative INGN 201 (Ad5CMV-p53) gene therapy followed by chemoradiotherapy for advanced, resectable squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx: report of the Southwest Oncology Group.

Yoo GH, Moon J, Leblanc M, Lonardo F, Urba S, Kim H, Hanna E, Tsue T, Valentino J, Ensley J, Wolf G.

Arch Otolaryngol Head Neck Surg. 2009 Sep;135(9):869-74. doi: 10.1001/archoto.2009.122.

PMID:
19770418
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Feasibility study of S-1 for resectable gastric cancer with peritoneal seeding.

Fujitani K, Tsujinaka T, Hirao M.

Hepatogastroenterology. 2003 May-Jun;50(51):889-92.

PMID:
12828112
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk